Exhibit
10.1


 


EXPLANATORY
NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND
(II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.





 






Response
to AIM ImmunoTech’s


Request
for Proposal for Trial Services to


Support
a Phase II Study of Ampligen in Patients


with
Post-COVID Conditions


 


June
13, 2022


 





 





 








    	 



     


    

 


EXPLANATORY
NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND
(II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.


 





 


Important
Information


 


This
proposal for a Project Work Order is provided to AIM ImmunoTech Inc (AIM) for the purpose of its evaluation and the information contained
herein is not intended to be used by (AIM) for any other purpose than the subject of this proposal. (AIM) agrees not to voluntarily disclose
any of the information contained herein to any third party without the prior written consent of Amarex Clinical Research, LLC (Amarex).


 


This
proposal document is subject to negotiation and, when the final version is signed by both parties, shall create a Project Work Order
with legal obligations on the part of both parties.


 


Proposal
Expiration Date: August 13, 2022


 


Prepared
for:


 


AIM
ImmunoTech Inc


783
Jersey Avenue


New
Brunswick, NJ 08901


Phone:
352-260-7797


Fax:
724-260-6742


 


Prepared
by:


 


Amarex
Clinical Research, LLC


20201
Century Boulevard, Suite 450


Germantown,
MD 20874


Phone:
(301) 528-7000


Fax:
(301) 528-2300


 






    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page i



     


    

 






EXPLANATORY
NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND
(II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.


 





 


Our
Understanding of AIM’s Needs


 


Based
on our discussions with AIM, Amarex understands that AIM plans to conduct a trial entitled: “A Randomized, Double Blind, Placebo
Controlled Study to Evaluate the Efficacy and Safety of Ampligen® in Patients with Post-COVID Conditions.” The study
will be conducted at up to 10 sites in the United States. No interim analysis is planned.


 


Study
Parameters




Following
is a list of study parameters Amarex has used in order to prepare this proposal response:


 


Table
3. Study Parameters Used to Prepare This Proposal


 


	STUDY
    PARAMETERS	 
	Number
    of sites	10
	Number
    of countries participating in study	1
	Number
    of subjects screened	170
	Number
    of subjects randomized/enrolled	80
	Number
    of subjects completed	80
	SITE
    MONITORING AND AUDITING	 
	Number
    of qualification sites	20
	Number
    of site initiation visits 	10
	Number
    of interim monitoring sites	40
	Number
    of closeout visits 	10
	IRB
    MANAGEMENT	 
	Number
    of Local IRB to manage 	10
	Number
    of Central IRB to manage	1
	Number
    of DSMB meetings to review data	1
	Number
    of statistical tables per DSMB	10/10
	Number
    of statistical listings per DSMB	10/10
	MEDICAL
    MONITORING	 
	Estimated
    number of SAEs	5
	Estimated
    number of reportable events	1
	DATA
    MANAGEMENT 	 
	Estimated
    Number of Adverse Events, Concomitant Medications, and Medical Histories to code	2,210
	Number
    of unique pages in eCRF book	20
	Number
    of central labs & vendors	2
	BIOSTATISTICS	 
	Number
    of stat. tables for final analysis (uniques/replicates)	30/20
	Number
    of listings for final analysis (uniques/replicates)	30/20
	Number
    of graphs for final analysis (unique/replicate)	5/0
	CLINICAL
    STUDY REPORT WRITING	 
	Write
    final clinical trial report 	Yes
	PROJECT
    MANAGEMENT	 
	Number
    of months for project setup	2
	Number
    of months for enrollment	4
	Number
    of months for follow-up (treatment period)	3
	Number
    of months of active study phase for monitoring	7
	Number
    of months for close out	2
	Number
    of months of project management (including set up and close out)	11


 






    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page 1



     


    

 







EXPLANATORY
NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND
(II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.


 





 


Proposed
Amarex Direct Services Budget


(US
Dollars)


 


	 AMAREX DIRECT SERVICES FEES

     
	 	 
	Bid
    ID	Service	Unit
    Description	 Unit
    Cost $ 	No.
    

    Units	 Total
    

    Cost $ 	 Category
    

    Total $ 
	B	PROJECT
    MANAGEMENT	 	 	 	 	 
	 	Meetings,
    Training, and Study Start Up	 	 	 	 	 
	11	Prepare
    for and Attend Kick-off Meeting & Study Start-Up	per
    protocol	 $    [***]
    	1	 $    [***]
    	 
	16	Prepare
    for and Attend Project Team Training 	per
    day	 $    [***]	1	 $    [***]	 
	 	Communication
    and Tracking	 	 	 	 	 
	17	Coordinate
    Amarex's Internal Project Team	per
    month	 $     [***]   	11	 $     [***]   	 
	18	Communicate
    with Sponsor 

    (includes standard teleconferences with activities reports and emails)	per
    month	 $    [***]
    	11	 $    [***]
    	 
	19	Manage
    Central Labs/Vendors	per
    lab-vendor/per month	 $    [***]	14	 $    [***]	 
	20	Tracking
    Systems Setup	fixed
    fee	 $    [***]
    	1	 $    [***]
    	 
	27.1	Management
    of Payments to Sites, IRBs, Labs, and/or Vendors	per
    payment / site, IRB or vendor	 $    [***]	61	 $    [***]	 $       [***]
    
	D	PRODUCT
    MANAGEMENT	 	 	 	 	 
	59	Set
    up of WebView IRT product supply tracking and email alert system.  Track drug shipments to sites, supply depots, auto-email
    requests for resupply based on randomization.  Require acknowledgement email from supply depot.	per
    project	 $    [***]
    	1	 $    [***]
    	 
	60	Maintenance
    for WebView IRT Product Resupply and Tracking	per
    site per month	 $    [***]	20	 $    [***]	 
	63	Support
    Initial Drug / Device Shipments	per
    site per shipment	 $    [***]
    	10	 $    [***]
    	$       [***]
	E	DATA
    MANAGEMENT SERVICES	 	 	 	 	 
	 	Data
    Management	 	 	 	 	 
	65	Develop
    Data Management Plan	per
    project	 $    [***]
    	1	 $    [***]
    	 
	73	Standard
    Data Cleaning (Run edit checks; generate, process, and track data queries)	per
    query	 $    [***]	800	 $    [***]	 
	78	Develop
    Edit Specifications	per
    project	 $    [***]
    	1	 $    [***]
    	 
	79	Conduct
    QC Audit of Interim Clinical Database 

    (5% of pts (min 5 max 50) for all data per lock)	per
    subject	 $    [***]	2	 $    [***]	 
	 	Data
    Operations	 	 	 	 	 
	86	Program
    Edit Checks	per
    edit check	 $    [***]
    	200	 $    [***]
    	 
	88	Set
    Up Data Transfer from Vendors	fixed
    cost/per vendor	 $    [***]	2	 $    [***]	 
	89	Receive
    and Reconcile Headers of Clean Data from Vendors	per
    transfer/per vendor	 $    [***]
    	14	 $    [***]
    	 
	91	Set
    Up Transfer of Final SAS Data to Sponsor 

    (in Amarex's format)	per
    dataset	 $    [***]	40	 $    [***]	 
	92	Perform
    Data Transfer to Sponsor 

    (Including export of final SAS Analysis Datasets)	per
    transfer	$    [***]	1	$    [***]	 
	 	EDC
    Support	 	 	 	 	 
	96	Prepare
    EDC Manual and Completion Instructions (includes up to 1 round of edits)	per
    manual	 $    [***]
    	1	 $    [***]
    	 
	97	Prepare
    User Acceptance Testing (UAT) Management Plan	per
    document	 $    [***]	1	 $    [***]	 
	98	Conduct
    QC of EDC Database	per
    subject enrolled	 $    [***]
    	80	 $    [***]
    	 
	99	Provide
    Electronic Data Capture Help Desk 	per
    site/per month	 $    [***]	70	 $    [***]	$       [***]
	 	WEBVIEW
    EDC PROGRAMMING	 	 	 	 	 
	101	Development
    of CRF Screen Shots	per
    unique page	 $    [***]
    	20	 $    [***]
    	 
	102	WebView
    EDC Programming (Initiation)	per
    study	 $    [***]	1	 $    [***]	 
	103	WebView
    EDC Programming (UAT 1)	per
    study	 $    [***]
    	1	 $    [***]
    	 
	104	WebView
    EDC Programming (System Activation)	per
    study	 $    [***]	1	 $    [***]	 
	105	WebView
    EDC Maintenance	per
    month	 $    [***]	9	 $    [***]	 $       [***]
	F	CLINICAL
    SITE SERVICES	 	 	 	 	 
	 	Site
    Identification and Contracting	 	 	 	 	 
	106	Prepare
    Site Identification Plan	per
    plan	 $    [***]
    	1	 $    [***]
    	 
	107	Perform
    Site Identification and Present Sites for Site Qualification Visits	per
    site recommended	 $    [***]	15	 $    [***]	 
	108	Develop
    Site Contracts (includes up to 2 rounds of edits)	per
    contract	 $    [***]
    	1	 $    [***]
    	 
	109	Negotiate
    Site Contract CTAs	per
    site	 $    [***]	10	 $    [***]	 
	110	Negotiate
    Site Contract Budgets	per
    site	 $    [***]
    	10	 $    [***]
    	 
	 	IRB
    and Ethics Committee Management	 	 	 	 	 
	112	Submit
    and Obtain Initial Approval of Local IRB	per
    submission per Local IRB	 $    [***]
    	10	 $    [***]
    	 
	113	Submit
    and Obtain Initial Approval of Central IRB 	per
    submission per Central IRB	 $    [***]	1	 $    [***]	 
	116	Review
    and Approve IRB Informed Consent Comments	per
    IRB	 $    [***]
    	11	 $    [***]
    	 
	117	Review
    and Approve Site Informed Consent Prior to IRB Submission	per
    site	 $    [***]	10	 $    [***]	 
	 	Site
    Regulatory Document Collection	 	 	 	 	 
	120	Set
    Up Trial Master File	per
    study	 $    [***]	1	 $    [***]	 
	121	Set
    Up Investigator/Site Regulatory Files	per
    site	 $    [***]
    	10	 $    [***]
    	 
	122	Conduct
    Ongoing Regulatory Document Collection, Review, Tracking, and Maintenance of Trial Master File	per
    site/per month	 $    [***]	70	 $    [***]	 
	 	Monitoring
    Services	 	 	 	 	 
	123	Prepare
    Study Operations Manual (includes up to 2 rounds of edits)	per
    project	 $    [***]
    	1	 $    [***]
    	 
	124	Prepare
    Monitoring Guidelines (includes up to 2 round of edits)	per
    project	 $    [***]	1	 $    [***]	 
	125	Perform
    Site Management	per
    site/per month 	 $    [***]
    	90	 $    [***]
    	 
	127	Prepare
    Documents for Site Initiation	per
    project	 $    [***]	1	 $    [***]	 
	128	Conduct
    Site Qualification Visits (includes prep and visit report in Amarex format)	per
    one-day visit	 $    [***]	20	 $    [***]	 
	129	Conduct
    Study Initiation Visits (includes prep and visit report in Amarex format)	per
    one-day visit	 $    [***]
    	10	 $    [***]
    	 
	130	Conduct
    Interim Monitoring Visits (includes prep and visit report in Amarex format)	per
    one-day visit	 $    [***]	40	 $    [***]	 
	131	Conduct
    Close Out Visits (includes prep and visit report in Amarex format)	per
    one-day visit	 $    [***]
    	10	 $    [***]
    	 
	133	Travel
    Time for Monitoring Visits	per
    trip	 $    [***]	80	 $    [***]	 $       [***]
    



 






    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page 2



     


    

 



EXPLANATORY
                                            NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH
                                            (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.


 





 






	AMAREX
    DIRECT SERVICES FEES	 	 	 	 	 
	Bid
    ID	Service	Unit
    Description	 Unit
    Cost $ 	No.
    

    Units	 Total
    

    Cost $ 	 Category
    

    Total $ 
	G	SAFETY	 	 	 	 	 
	143	Set
    Up Tracking System and SAE/UADE Start Up	fixed
    fee	 $    [***]
    	1	 $    [***]
    	 
	144	Prepare
    Safety Management Plan (includes up to 1 round of edits)	per
    plan	 $    [***]	1	 $    [***]	 
	145	Prepare
    Medical Monitoring Plan (includes up to 1 round of edits)	per
    plan	 $    [***]
    	1	 $    [***]
    	 
	146	Set
    Up WebView EDC Safety Reporting Module	per
    project	 $    [***]	1	 $    [***]	 
	148	Collect,
    Process, Evaluate SAE/UADE or Pregnancy, and Prepare Narrative	per
    event	 $    [***]	5	 $    [***]	 
	149	Prepare
    CIOMS or MedWatch Form	per
    reportable event	 $    [***]
    	1	 $    [***]
    	 
	150	Prepare
    SAE/UADE Follow up Reports	per
    update	 $    [***]	TBD	       [***]
    	 
	153	Revise
    SAE/UADE Narratives for DSMB Meetings	per
    event/per meeting	 $    [***]
    	7	 $    [***]
    	 
	154	Distribute
    SAE/UADE "Dear Dr." Letters to Sites	per
    letter per site	 $    [***]	10	 $    [***]	 
	155	Submit
    Safety Reports to Regulatory Authorities	per
    reportable event per country	 $    [***]	1	 $    [***]
    	 
	159	Set
    Up of Coding System to Code AEs, ConMeds, and Histories	fixed
    cost 	 $    [***]
    	1	 $    [***]	 
	160	Prepare
    Medical Coding Plan (includes up to 2 rounds of edits)	per
    plan	 $    [***]	1	 $    [***]	 
	161	Code
    Adverse Events, Medications, and Histories

    (Using MedDRA and WHO Drug ATC Level)	per
    term	 $    [***]	2210	 $    [***]
    	 $       [***]
	H	DATA
    SAFETY MONITORING BOARD (DSMB)	 	 	 	 	 
	163	Establish
    and Manage 3-Member DSMB	fixed
    cost	 $    [***]
    	1	 $    [***]
    	 
	164	Develop
    DSMB Charter (includes up to 1 round of edits)	per
    project	 $    [***]	1	 $    [***]	 
	165	Organize,
    Conduct and Participate in DSMB Meetings	per
    meeting	 $    [***]
    	2	 $    [***]
    	 
	166	Prepare
    Statistical Analysis Plan for DSMB	per
    project	 $    [***]	1	 $    [***]	 
	167	Program
    and Produce Unique Tables for DSMB	per
    unique table	 $    [***]	10	 $    [***]
    	 
	168	Program
    and Produce Replicate Tables for DSMB	per
    replicate table	 $    [***]
    	10	 $    [***]	 
	169	Program
    and Produce Unique Listings for DSMB	per
    unique listing	 $    [***]	10	 $    [***]
    	 
	170	Program
    and Produce Replicate Listings for DSMB	per
    replicate listing	 $    [***]
    	10	 $    [***]	 
	172	Prepare
    Statistical Report for DSMB Meeting (open and closed session reports, includes up to 1 round of edits)	per
    meeting	 $    [***]	1	 $     [***]
    	$       [***]
	I	RANDOMIZATION
    AND ENROLLMENT	 	 	 	 	 
	176	Develop
    WebView IRT Enrollment/Randomization Module	per
    project	 $    [***]	1	 $    [***]	 
	177	Generate
    WebView IRT Randomization Code and Plan	per
    project	 $    [***]
    	1	 $    [***]
    	 
	178	Conduct
    WebView IRT Enrollment/Randomization Maintenance	per
    month	 $    [***]	7	 $    [***]	 $       [***]
	J	BIOSTATISTICS	 	 	 	 	 
	182	Prepare
    Statistical Analysis Plan (includes list of TLGs in Amarex standard format, and data set conventions)	per
    project	 $    [***]
    	1	 $    [***]	 
	189	Program
    Tables for Final Analysis (unique tables)	per
    unique table	 $    [***]	30	 $    [***]
    	 
	190	Program
    Tables for Final Analysis (replicate tables)	per
    replicate table	 $    [***]
    	20	 $    [***]	 
	191	Program
    Listings for Final Analysis (unique listings)	per
    unique listing	 $    [***]	30	 $    [***]	 
	192	Program
    Listings for Final Analysis (replicate listings)	per
    replicate listing	 $    [***]	20	 $    [***]
    	 
	193	Program
    Graphs for Final Analysis (unique graph)	per
    unique graph	 $   [***]
    	5	 $    [***]	 
	195	Conduct
    QC Audit of Stats	per
    lock	 $    [***]
    	1	 $    [***]
    	 
	198	Production
    and Review of Tables, Listings, and Graphs for Final Analysis (per unique display)	per
    unique display	 $    [***]	65	 $    [***]	 
	199	Production
    and Review of Tables, Listings, and Graphs for Final Analysis (per replicate display)	per
    replicate display	 $    [***]	40	 $    [***]	 
	 	Other	 	 	 	 	 
	202	Base
    ADaM CDISC Conversion (mapping and programming)	per
    conversion	 $   [***]
    	1	 $    [***]
    	 $       [***]
	K	MEDICAL
    WRITING	 	 	 	 	 
	211	Prepare
    Final Clinical Study Report Shell 

    (ICH Format) - includes up to one round of edits	per
    report	 $    [***]
    	1	 $    [***]
    	 
	212	Prepare
    Subject Narratives for CSR	per
    narrative	 $    [***]	8	 $    [***]	 
	213	Prepare
    Final Clinical Study Report (ICH Format) with Appendices - includes up to two rounds of edits	per
    report	 $    [***]	1	 $    [***]	 
	214	Conduct
    QC Audit of Clinical Study Report	per
    report	 $   [***]
    	1	 $    [***]
    	$       [***]
	M	GENERAL
    & ADMINISTRATIVE EXPENSES	 	 	 	 	 
	221	G&A
    Expenses	per
    month	 $   [***]
    	11	 $    [***]
    	 $       [***]
	 	 	 	 	 	 	 
	 	TOTAL
    OF ACTIVITY-BASED COSTING	 	 	 	 $   [***]	 


 




    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page 3



     


    

 



EXPLANATORY
                                            NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE
                                            IT IS BOTH (I) NOT MATERIAL AND
                                            (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.


 





 


The
unit costs provided in the budget are discounted according to certain economies of scale. A reduction of tasks or units could result
in higher unit costs for remaining tasks or units.


 


Additional
units in excess of those planned above will be billed at the same unit rate as shown above.


 


Amarex
budgets services by ‘tasks’ as opposed to by hours. Each task has a fixed unit price associated with it and an estimated
number of units proposed for the project. Please examine the estimated number of units for each task carefully to make sure they agree
with your expectation. Amarex reserves the right to increase its rates on an annual basis. This increase will not exceed 5% per year.


 


Estimated
Pass-Through Costs


 



 





	ESTIMATED
    PASS THROUGH COSTS  
	Bid
    ID	Expense	Unit
    Description	Unit


    Cost $	No.
     Units	Total

 Cost $ 	Category


    Total $
	A	TRAVEL
    AND MEETINGS
	 	US
    Monitoring Visit Costs (Travel and Living)	 	 	 	 	 
	1	Airfare	per
    flight	 $    [***]	80	 $    [***]	 
	2	Ground
    Transportation	per
    day	 $    [***]	120	 $    [***]	 
	3	Parking	per
    trip	 $    [***]
    	80	 $    [***]
    	 
	4	Hotel
    Accommodations	per
    night	 $    [***]	40	 $    [***]	 
	5	Meals
    	per
    day	 $    [***]
    	120	 $    [***]
    	 $     [***]
    
	B	PRINTING
    & ASSEMBLY OF STUDY MATERIALS	 	 	 	 	 
	35	Investigator
    Study Binders Printing and Assembly	per
    site	 $    [***]	11	 $    [***]	 
	36	Miscellaneous
    Printing/Copying 	per
    site per month	 $    [***]
    	70	 $    [***]
    	$      [***]
	C	SHIPPING
    COSTS (CRFs, Study Binders, etc.)	 	 	 	 	 
	39	Overnight
    delivery (UPS/FedEx)	per
    site per month	 $
       [***]	70	 $
       [***]	$      [***]
	E	MISCELLANEOUS	 	 	 	 	 
	48	DSMB
    Honorarium	per
    person per meeting	 $    [***]
    	6	 $    [***]	 
	51	Ad
    Hoc Electronic Data Transfers Over 12MB 	per
    transfer	 $    [***]	11	 $    [***]	 
	52	WebEx	per
    month	 $    [***]
    	11	 $    [***]
    	$      [***]
	 	 	 	 	 	 	 
	 	TOTAL OF ESTIMATED PASS THROUGHS	 	 	 $    [***]	 


 


Pass-through
expenses, such as: approved travel, document shipping and printing, and other project related out-of-pocket expenses incurred by Amarex
in the conduct of the study will be invoiced to AIM at the actual cost. These expenses will be supported by acceptable documentation
or actual receipts.


 


Third
Party Costs




Third party costs are not included in this proposal.
They can be further discussed with AIM.


 





v






    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page 4



     


    

 


EXPLANATORY
NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND
(II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.


 









 


Payment
Schedule and Terms


Payment
Schedule for Services




The payment terms and obligations for the services
outlined in this proposal are as follows:


 


	Payment
    Description	 	Percentage
    Due 	 	Amount
	Execution
    of Project Work Order	 	20%	 	$
    [***]
	Monthly
    Unit-Based Billing	 	Balance
    Due	 	$
    [***]
	TOTAL	 	 	 	$
    [***]


 


Payment
                                            Schedule for Pass-Through Expenses


 












Pass-through
expenses such as approved travel, document shipping and printing, and other reasonable expenses will be invoiced to AIM at cost. These
expenses will be supported by acceptable documentation or actual receipts and will be invoiced on a monthly basis.


 


Payment
                                            Terms


 






 





		■	Payments
                                            are due 30 days after delivery of an invoice.



		■	Late
                                            payment fee: 1% per month interest on all past due, unpaid balances.



		■	Amarex
                                            Clinical Research, LLC Tax ID: [***]



		■	Please
                                            include Invoice numbers on all payments



		■	Payments
                                            will be sent to Amarex’s partner company NSF International



		■	Payments
                                            will be wire transferred to the NSF International bank account at:



 


[***]


 





v


 






    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page 5



     


    






 


EXPLANATORY
NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY
HARMFUL IF PUBLICLY DISCLOSED.


 





 


Project
Work Order Signatures


 


In
Witness Whereof, AIM ImmunoTech Inc. and Amarex Clinical Research, LLC agree to all items and payment terms and conditions presented
in this Project Work Order as indicated by the signatures below of their respective duly authorized representatives as of the “Effective
Date”, appearing below.


 


ACKNOWLEDGED,
ACCEPTED, AND AGREED TO:


 





	For and on behalf of AIM ImmunoTech Inc.:	 	For and on behalf of Amarex Clinical Research, LLC:
	Print Name:	 	Thomas K Equels	 	Print Name:	 	Kazem Kazempour
	Signature:	 	/s/Thomas K Equels	 	Signature:	 	/s/Kazem Kazempour
	Title:	 	Chief Executive Officer	 	Title:	 	President and CEO (Member)
	Effective Date:	 	June 14, 2022	 	Effective Date:	 	June 13, 2022


   


v


 






    	Amarex’s Response to AIM’s Request for Proposal	6/13/2022
	Amarex Clinical Research, LLC Confidential and Proprietary Information	Page 6